Products for Research Use Only
RegisterLogin

Hepln-13

CAT: 0804-HY-118134-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-118134-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Hepln-13 is a potent and orally active Hepsin inhibitor with an IC50 of 0.33 μM. Hepln-13 can be used for the research of metastatic prostate cancer[1].
CAS Number
64369-13-7
Product Name Alternative
Clodantoin, Xenazoic acid; CV58913
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hepln-13.html
Purity
99.34
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
BrC1=CC=C(C=C1)C(N2)NC3=C4C2=CC=CC4=CC=C3
Molecular Formula
C17H13BrN2
Molecular Weight
325.20
Precautions
H302, H315, H319, H335
References & Citations
[1]Tang X, et al. Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis. Oncotarget. 2014;5 (5) :1352-1362.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-N086713-Oxyingenol-13-dodecanoate
HY-W98953413-Methoxy-13-oxotridecanoic acid
HY-W13016713- (Benzyloxy) -13-oxotridecanoic acid
HY-W70350212- (Methyl-d3) tridecanal-12,13,13,13-d4
HY-N15009Kynapcin-13
HY-170675Ferroptosis-IN-13
HY-155240Tyrosinase-IN-13
HY-149241-01SHP2-IN-13
HY-162268MALT1-IN-13
HY-161571LRRK2-IN-13

Alternative Products

CatalogName
T25492-01Hepln-13
I8435-13Interleukin 13 (IL-13)
MBS590055-01Interleukin-13 (IL-13)

Popular Products